Company profile: Nebion
1.1 - Company Overview
Company description
- Provider of precise curation and advanced analytics of public and private studies to enable the future of genomic research.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nebion
Affinergy
HQ: United States
Website
- Description: Provider of application-specific coatings and medical devices for orthopedic and cardiovascular markets; diagnostic assays including an ApoL1 G0 variant blood test to inform kidney transplantation, therapeutic drug monitoring for Tacrolimus, Vancomycin and Hepcidin, and immune profile diagnostics for autoimmune diseases; plus peptide and antibody display services to identify interactions and binding affinities, and epitope mapping.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Affinergy company profile →
3D Bio-Tissues
HQ: United Kingdom
Website
- Description: Provider of bio-equivalent tissues for clinical and cellular agriculture, including 3DBT corneas engineered to match human donor corneas, Tissue Templating Technology for structured, scalable tissues without animal components, City-Mix culture media supplement to enhance cell performance, and Etsyl, a lipopeptide that stimulates collagen production for cosmetic and pharmacological use.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 3D Bio-Tissues company profile →
Inscripta
HQ: United States
Website
- Description: Provider of digital genome engineering solutions for life sciences.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inscripta company profile →
Sepax Technologies
HQ: United States
Website
- Description: Provider of chromatography columns and resins for biomolecule separation and analysis, including ion exchange (Proteomix IEX), hydrophobic interaction (Proteomix HIC Butyl), size exclusion for ADCs and other biomolecules (Monomix MC SEC resins; Zenix-C SEC), reverse phase for DAR analysis (Proteomix RP-1000), and weak cation exchange for monoclonal antibodies (Antibodix WCX), plus method development services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sepax Technologies company profile →
NorthStar Medical Radioisotopes
HQ: United States
Website
- Description: Provider of radioisotopes and radiopharmaceutical CDMO/CMO services for the nuclear medicine market, producing Actinium-225 (Ac-225) and Copper-67 (Cu-67) in scalable, commercial quantities via electron beam accelerators, and delivering end-to-end contract development and manufacturing from research to commercialization, with environmentally friendly accelerator-based production of multiple isotopes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NorthStar Medical Radioisotopes company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nebion
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nebion
2.2 - Growth funds investing in similar companies to Nebion
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nebion
4.2 - Public trading comparable groups for Nebion
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →